Bank of New York Mellon Corp Has $4.55 Million Stock Holdings in Phreesia, Inc. (NYSE:PHR)

Bank of New York Mellon Corp lifted its holdings in Phreesia, Inc. (NYSE:PHR) by 8.4% during the 2nd quarter, Holdings Channel reports. The fund owned 214,430 shares of the company’s stock after acquiring an additional 16,614 shares during the quarter. Bank of New York Mellon Corp’s holdings in Phreesia were worth $4,546,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the stock. Russell Investments Group Ltd. increased its position in shares of Phreesia by 5,462.3% in the 4th quarter. Russell Investments Group Ltd. now owns 3,838 shares of the company’s stock valued at $89,000 after buying an additional 3,769 shares in the last quarter. EntryPoint Capital LLC acquired a new position in shares of Phreesia during the 1st quarter worth about $169,000. Quadrature Capital Ltd bought a new stake in shares of Phreesia in the 1st quarter valued at about $202,000. ProShare Advisors LLC raised its holdings in Phreesia by 8.6% in the 1st quarter. ProShare Advisors LLC now owns 9,522 shares of the company’s stock valued at $228,000 after acquiring an additional 751 shares during the period. Finally, Trexquant Investment LP bought a new position in shares of Phreesia during the fourth quarter worth approximately $249,000. Institutional investors own 92.10% of the company’s stock.

Insider Activity at Phreesia

In related news, CEO Chaim Indig sold 2,644 shares of Phreesia stock in a transaction that occurred on Tuesday, July 16th. The shares were sold at an average price of $23.74, for a total transaction of $62,768.56. Following the transaction, the chief executive officer now directly owns 1,219,361 shares of the company’s stock, valued at $28,947,630.14. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other Phreesia news, CEO Chaim Indig sold 2,644 shares of Phreesia stock in a transaction on Tuesday, July 16th. The shares were sold at an average price of $23.74, for a total value of $62,768.56. Following the transaction, the chief executive officer now directly owns 1,219,361 shares of the company’s stock, valued at $28,947,630.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Evan Roberts sold 1,669 shares of Phreesia stock in a transaction on Tuesday, July 16th. The stock was sold at an average price of $23.74, for a total transaction of $39,622.06. Following the completion of the transaction, the chief operating officer now directly owns 753,234 shares in the company, valued at $17,881,775.16. The disclosure for this sale can be found here. Insiders have sold a total of 46,364 shares of company stock valued at $1,132,627 over the last ninety days. 5.80% of the stock is owned by company insiders.

Phreesia Stock Performance

Shares of PHR stock opened at $24.68 on Friday. The firm has a market cap of $1.42 billion, a price-to-earnings ratio of -11.37 and a beta of 0.93. The company’s 50 day moving average is $23.72 and its 200 day moving average is $22.75. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.03. Phreesia, Inc. has a 52-week low of $12.05 and a 52-week high of $29.16.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. JPMorgan Chase & Co. raised their price objective on Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a research report on Monday, September 9th. Robert W. Baird increased their price objective on Phreesia from $31.00 to $34.00 and gave the company an “outperform” rating in a report on Friday, September 6th. KeyCorp reduced their price objective on Phreesia from $27.00 to $25.00 and set an “overweight” rating for the company in a report on Thursday, July 11th. Stephens reiterated an “overweight” rating and issued a $28.00 price objective on shares of Phreesia in a research report on Friday, May 31st. Finally, Truist Financial raised their price target on Phreesia from $29.00 to $31.00 and gave the company a “buy” rating in a research report on Friday, September 6th. One equities research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat, Phreesia presently has a consensus rating of “Moderate Buy” and a consensus target price of $29.42.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.